MICHAEL GLADSTONE

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: GLADSTONE

Related Companies

Titles

Company Name

Related People

DIRECTOR

AKRIVEIA THERAPEUTICS, LLC

BENJAMIN AUSPITZ, THOMAS BECK, DAVID GRAYZEL, SIMON TOMLINSON

EXECUTIVE OFFICER

ATLAS VENTURE FUND XII, L.P.

N/A ATLAS VENTURE ASSOCIATES XII, L.P., N/A ATLAS VENTURE ASSOCIATES XII, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, DAVID GRAYZEL, JASON RHODES

DIRECTOR

DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC

DANIEL BECKER, JEREMY BENDER, DEREK DIROCCO, NATALIE HOLLES, JOHN JOSEY, JULIE PAPANEK GRANT

EXECUTIVE OFFICER

ATLAS VENTURE OPPORTUNITY FUND II, L.P.

N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, DAVID GRAYZEL, JASON RHODES

EXECUTIVE OFFICER

ATLAS VENTURE FUND XIII, L.P.

N/A ATLAS VENTURE ASSOCIATES XIII, L.P., N/A ATLAS VENTURE ASSOCIATES XIII, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, DAVID GRAYZEL, JASON RHODES

EXECUTIVE OFFICER

ATLAS VENTURE FUND XIV, L.P.

N/A ATLAS VENTURE ASSOCIATES XIV, L.P., N/A ATLAS VENTURE ASSOCIATES XIV, LLC, KEVIN BITTERMAN, BRUCE BOOTH, DAVID GRAYZEL, JASON RHODES

EXECUTIVE OFFICER

ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.

N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY III, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY III, LLC, KEVIN BITTERMAN, BRUCE BOOTH, JASON RHODES

DIRECTOR

CALDERA THERAPEUTICS, INC.

MICHELLE DOIG, AARON ROYSTON, XIAODI SU, PRAVEEN TIPIRNENI

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2026-01-08

D

VENTURE CAPITAL FUND

NOT APPLICABLE

2025-08-26

D

VENTURE CAPITAL FUND

NOT APPLICABLE

2024-12-04

D

VENTURE CAPITAL FUND

NOT APPLICABLE

2022-03-02

D

VENTURE CAPITAL FUND

NOT APPLICABLE

2021-09-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2021-02-01

D

VENTURE CAPITAL FUND

NOT APPLICABLE

2020-05-20

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-01-23